Manufacture of the product and process controls The process is considered to be a standard manufacturing process. The 12.5 mg tablet is not coated. The 25 mg, 50 mg, 100 mg, 150 mg and 200 mg tablets are coated with a non-functional cosmetic film coat. Process parameters and IPC were identified during development.The acceptable process ranges were established in systematic way using QbD principles. The proposed process validation protocols are adequate. The applicant confirms that the manufacturing process will be validated before any product is made commercially available, which is considered sufficient for this type of product and manufacturing process. The applicant commits to conducting shipping validation under protocol.